| |
Numerical display
|
LN positive (n = 12)
|
LN negative (n = 48)
|
Test
|
P value
|
|---|
|
Age in years
|
Mean (95%CI)
|
45.8 (38.5–53.0)
|
46.7 (43.3–50.0)
|
T-test
|
0.732
|
|
FIGO stage
|
|
Ia2
|
n (%)
|
0 (0.0)
|
2 (4.2)
|
χ
2
|
0.134
|
|
Ib1
|
n (%)
|
6 (50.0)
|
37 (77.1)
| | |
|
Ib2
|
n (%)
|
2 (16.7)
|
2 (4.2)
| | |
|
IIa
|
n (%)
|
4 (33.3)
|
7 (14.6)
| | |
|
Histological subtype
|
|
Squamous cell carcinoma
|
n (%)
|
11 (91.7)
|
29 (60.4)
|
χ
2
|
0.119
|
|
Adenocarcinoma
|
n (%)
|
1 (8.3)
|
17 (35.4)
| | |
|
Adenosquamous carcinoma
|
n (%)
|
0 (0.0)
|
2 (4.2)
| | |
|
Lymph nodes
|
|
Number of positive LN
|
Median (min-max)
|
1 (1–7)
|
0 (0–0)
|
Mann–Whitney
|
<0.001
|
|
Number of removed LN
|
Median (min-max)
|
28 (4–50)
|
34 (18–89)
|
Mann–Whitney
|
0.241
|
|
LVSI
|
|
Positive
|
n (%)
|
10 (83.3)
|
16 (33.3)
|
χ
2
|
0.005
|
|
Negative
|
n (%)
|
2 (16.7)
|
32 (66.7)
| | |
|
Follow-up
|
|
Follow-up (in months)
|
Mean (95%CI)
|
61.8 (42.0–81.5)
|
61.7 (49.0–66.5)
|
T-test
|
0.997
|
|
Recurrence
|
|
Recurrence
|
n (%)
|
3 (25.0)
|
7 (14.6)
|
χ
2
|
0.665
|
|
No recurrence
|
n (%)
|
9 (75.0)
|
41 (85.4)
| | |
- Abbreviations: LN = lymph node; FIGO = International Federation of Gynecology and Obstetrics; LVSI = lymphvascular space involvement.
